Carter, Corey A. External Entity

Publications

Sort by

Selected publications

  • Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.  The Lancet. Oncology2014 Academic Article GET IT
    Times cited: 47

Other